Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eder

Showing results (751-760 of 5,175) with videos related to

Pageof 518
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 31, 2016
An increase in serum tumour necrosis factor-α during anti-tumour necrosis factor-α therapy for Crohn's disease - A paradox or a predictive index?Piotr Eder, Katarzyna Korybalska, Liliana Łykowska-Szuber, et al.
World Journal of Gastroenterology|January 21, 2017
Trefoil factor-3 is not a useful marker of mucosal healing in Crohn's disease treated with anti-TNF-α antibodiesPiotr Eder, Kamila Stawczyk-Eder, Katarzyna Korybalska, et al.
European Journal of Internal Medicine|July 23, 2015
The diagnostic usefulness of fecal lactoferrin in the assessment of Crohn's disease activityKatarzyna Klimczak, Liliana Lykowska-Szuber, Piotr Eder, et al.
Folia Histochemica Et Cytobiologica|November 9, 2013
Anti-TNF antibodies do not induce the apoptosis of lamina propria mononuclear cells in uninflamed intestinal tissue in patients with Crohn's diseasePiotr Eder, Liliana Lykowska-Szuber, Iwona Krela-Kazmierczak, et al.
Cytokine|October 21, 2015
Association of serum VEGF with clinical response to anti-TNFα therapy for Crohn's diseasePiotr Eder, Katarzyna Korybalska, Liliana Lykowska-Szuber, et al.
Journal of Applied Genetics|September 2, 2023
Variants of the CASP9 gene as candidate markers for primary response to anti-TNF therapy in Crohn's disease patientsLiliana Lykowska-Szuber, Michal Walczak, Kamila Stawczyk-Eder, et al.
Archives of Medical Science : AMS|May 22, 2015
Is faecal calprotectin equally useful in all Crohn's disease locations? A prospective, comparative studyKamila Stawczyk-Eder, Piotr Eder, Liliana Lykowska-Szuber, et al.
Scientific Reports|May 21, 2015
Magnetic resonance enterographic predictors of one-year outcome in ileal and ileocolonic Crohn's disease treated with anti-tumor necrosis factor antibodiesPiotr Eder, Michal Michalak, Katarzyna Katulska, et al.
Archives of Medical Science : AMS|January 21, 2016
Disturbances in apoptosis of lamina propria lymphocytes in Crohn's diseasePiotr Eder, Liliana Łykowska-Szuber, Iwona Krela-Kaźmierczak, et al.
Przeglad Gastroenterologiczny|October 8, 2016
Intestinal healing after anti-TNF induction therapy predicts long-term response to one-year treatment in patients with ileocolonic Crohn's disease naive to anti-TNF agentsPiotr Eder, Liliana Łykowska-Szuber, Katarzyna Katulska, et al.
Pageof 518

Showing results (751-760 of 5,175) with videos related to

Sort By:
Pageof 518
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 31, 2016
An increase in serum tumour necrosis factor-α during anti-tumour necrosis factor-α therapy for Crohn's disease - A paradox or a predictive index?Piotr Eder, Katarzyna Korybalska, Liliana Łykowska-Szuber, et al.
World Journal of Gastroenterology|January 21, 2017
Trefoil factor-3 is not a useful marker of mucosal healing in Crohn's disease treated with anti-TNF-α antibodiesPiotr Eder, Kamila Stawczyk-Eder, Katarzyna Korybalska, et al.
European Journal of Internal Medicine|July 23, 2015
The diagnostic usefulness of fecal lactoferrin in the assessment of Crohn's disease activityKatarzyna Klimczak, Liliana Lykowska-Szuber, Piotr Eder, et al.
Folia Histochemica Et Cytobiologica|November 9, 2013
Anti-TNF antibodies do not induce the apoptosis of lamina propria mononuclear cells in uninflamed intestinal tissue in patients with Crohn's diseasePiotr Eder, Liliana Lykowska-Szuber, Iwona Krela-Kazmierczak, et al.
Cytokine|October 21, 2015
Association of serum VEGF with clinical response to anti-TNFα therapy for Crohn's diseasePiotr Eder, Katarzyna Korybalska, Liliana Lykowska-Szuber, et al.
Journal of Applied Genetics|September 2, 2023
Variants of the CASP9 gene as candidate markers for primary response to anti-TNF therapy in Crohn's disease patientsLiliana Lykowska-Szuber, Michal Walczak, Kamila Stawczyk-Eder, et al.
Archives of Medical Science : AMS|May 22, 2015
Is faecal calprotectin equally useful in all Crohn's disease locations? A prospective, comparative studyKamila Stawczyk-Eder, Piotr Eder, Liliana Lykowska-Szuber, et al.
Scientific Reports|May 21, 2015
Magnetic resonance enterographic predictors of one-year outcome in ileal and ileocolonic Crohn's disease treated with anti-tumor necrosis factor antibodiesPiotr Eder, Michal Michalak, Katarzyna Katulska, et al.
Archives of Medical Science : AMS|January 21, 2016
Disturbances in apoptosis of lamina propria lymphocytes in Crohn's diseasePiotr Eder, Liliana Łykowska-Szuber, Iwona Krela-Kaźmierczak, et al.
Przeglad Gastroenterologiczny|October 8, 2016
Intestinal healing after anti-TNF induction therapy predicts long-term response to one-year treatment in patients with ileocolonic Crohn's disease naive to anti-TNF agentsPiotr Eder, Liliana Łykowska-Szuber, Katarzyna Katulska, et al.
Pageof 518